These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 8218358)
1. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Moghimi SM; Muir IS; Illum L; Davis SS; Kolb-Bachofen V Biochim Biophys Acta; 1993 Nov; 1179(2):157-65. PubMed ID: 8218358 [TBL] [Abstract][Full Text] [Related]
2. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Moghimi SM; Hedeman H; Muir IS; Illum L; Davis SS Biochim Biophys Acta; 1993 Jul; 1157(3):233-40. PubMed ID: 8323953 [TBL] [Abstract][Full Text] [Related]
3. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. Moghimi SM; Gray T Clin Sci (Lond); 1997 Oct; 93(4):371-9. PubMed ID: 9404230 [TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats. Moghimi SM; Hedeman H; Christy NM; Illum L; Davis SS J Leukoc Biol; 1993 Dec; 54(6):513-7. PubMed ID: 8245702 [TBL] [Abstract][Full Text] [Related]
5. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. Moghimi SM; Hawley AE; Christy NM; Gray T; Illum L; Davis SS FEBS Lett; 1994 May; 344(1):25-30. PubMed ID: 8181558 [TBL] [Abstract][Full Text] [Related]
6. Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo? Moghimi SM Biochim Biophys Acta; 1997 Jul; 1336(1):1-6. PubMed ID: 9271243 [TBL] [Abstract][Full Text] [Related]
7. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Norman ME; Williams P; Illum L Biomaterials; 1992; 13(12):841-9. PubMed ID: 1457677 [TBL] [Abstract][Full Text] [Related]
8. Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908. Moghimi SM; Pavey KD; Hunter AC FEBS Lett; 2003 Jul; 547(1-3):177-82. PubMed ID: 12860409 [TBL] [Abstract][Full Text] [Related]
9. Effect of splenic congestion associated with haemolytic anaemia on filtration of 'spleen-homing' microspheres. Moghimi SM; Hedeman H; Illum L; Davis SS Clin Sci (Lond); 1993 Jun; 84(6):605-9. PubMed ID: 8334806 [TBL] [Abstract][Full Text] [Related]
10. Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery. Armstrong TI; Moghimi SM; Davis SS; Illum L Pharm Res; 1997 Nov; 14(11):1629-33. PubMed ID: 9434285 [TBL] [Abstract][Full Text] [Related]
11. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. Al-Hanbali O; Rutt KJ; Sarker DK; Hunter AC; Moghimi SM J Nanosci Nanotechnol; 2006; 6(9-10):3126-33. PubMed ID: 17048527 [TBL] [Abstract][Full Text] [Related]
12. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging. Moghimi SM Biochim Biophys Acta; 1999 Oct; 1472(1-2):399-403. PubMed ID: 10572962 [TBL] [Abstract][Full Text] [Related]
13. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. Neal JC; Stolnik S; Garnett MC; Davis SS; Illum L Pharm Res; 1998 Feb; 15(2):318-24. PubMed ID: 9523321 [TBL] [Abstract][Full Text] [Related]
14. Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing. Pedraza CE; Nikolcheva LG; Kaartinen MT; Barralet JE; McKee MD Bone; 2008 Oct; 43(4):708-16. PubMed ID: 18656563 [TBL] [Abstract][Full Text] [Related]
15. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit. Khattab MA; Farr SJ; Taylor G; Kellaway IW J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819 [TBL] [Abstract][Full Text] [Related]
16. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. Neal JC; Stolnik S; Schacht E; Kenawy ER; Garnett MC; Davis SS; Illum L J Pharm Sci; 1998 Oct; 87(10):1242-8. PubMed ID: 9758684 [TBL] [Abstract][Full Text] [Related]
17. Influence of the surfactant concentration on the body distribution of nanoparticles. Araujo L; Löbenberg R; Kreuter J J Drug Target; 1999; 6(5):373-85. PubMed ID: 10342385 [TBL] [Abstract][Full Text] [Related]
18. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Moghimi SM Biochim Biophys Acta; 2002 Jun; 1590(1-3):131-9. PubMed ID: 12063176 [TBL] [Abstract][Full Text] [Related]
19. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. Carrstensen H; Müller RH; Müller BW Clin Nutr; 1992 Oct; 11(5):289-97. PubMed ID: 16840011 [TBL] [Abstract][Full Text] [Related]
20. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. Illum L; Davis SS; Müller RH; Mak E; West P Life Sci; 1987 Jan; 40(4):367-74. PubMed ID: 3807638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]